The primary responsibility of the independent Data
Site Search
Effective clinical development plans and good study design can save sponsors and investigators time and money, leading to faster development of potential new therapies for people with cystic fibrosis.
The Therapeutics Development Network includes over 90
Therapeutics Development Network investigators and research staff work every day to promote quality,
Access to antimicrobial tools can aid researchers in the discovery of new anti-infective treatments for cystic fibrosis.
Germs can spread in a number of ways, but the most common are by direct and indirect contact and through the air.
MRSA stands for methicillin-resistant Staphylococcus aureus. The bacteria can cause an infection on the skin and in the lungs. It is resistant to several common antibiotics. But MRSA can be treated with some antibiotics, nose drops, and other therapies.
Nontuberculous mycobacteria are a group of bacteria that live in soil, swamps, and water sources.
Cystic fibrosis biological samples are available to qualified researchers to help develop promising new studies that will support CF research and aid in drug development and drug discovery.